Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice.
Authors:
- 1 April 1999
- journal article
- Vol. 67 (4) , 1779-88
Abstract
The role of an extracellular cysteine protease encoded by the speB gene in group A Streptococcus (GAS) skin infection was studied with a mouse model. Mice were injected subcutaneously with a wild-type GAS serotype M3 strain or a cysteine protease-inactivated isogenic derivative grown to stationary phase. The mortality rate of mice injected with the M3 speB mutant strain was significantly decreased (P < 0.0008) compared to that of animals injected with the wild-type parental organism. The abscesses formed in animals infected with the cysteine protease mutant strain were significantly smaller (P < 0.0001) than those caused by the wild-type organism and slowly regressed over 3 to 4 weeks. In striking contrast, infection with the wild-type GAS isolate generated necrotic lesions, and in some animals the GAS disseminated widely from the injection site and produced extensive cutaneous damage. All of these animals developed bacteremia and died. GAS dissemination was accompanied by severe tissue and blood vessel necrosis. Cysteine protease expression in the infected tissue was identified by immunogold electron microscopy. These data demonstrate that cysteine protease expression contributes to soft tissue pathology, including necrosis, and is required for efficient systemic dissemination of the organism from the initial site of skin inoculation.Keywords
This publication has 48 references indexed in Scilit:
- Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection.Journal of Clinical Investigation, 1998
- Molecular, Serological, and Clinical Features of 16 Consecutive Cases of Invasive Streptococcal DiseaseClinical Infectious Diseases, 1998
- Streptococcal Superantigen, Mitogenic Factor, and Pyrogenic Exotoxin B Expressed byStreptococcus pyogenesPreparative Biochemistry & Biotechnology, 1997
- Relation Between Low Capacity Of Human Sera To Inhibit Streptococcal Mitogens And Serious Manifestation Of DiseaseThe Journal of Infectious Diseases, 1994
- Structural biochemistry and activation of matrix metalloproteasesCurrent Opinion in Cell Biology, 1993
- Microbiological features of current virulent strains of Group A streptococciThe Pediatric Infectious Disease Journal, 1991
- Association of exotoxin-producing Group A streptococci and severe disease in childrenThe Pediatric Infectious Disease Journal, 1991
- Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin ANew England Journal of Medicine, 1989
- Fibronectin: An Enhancer of Phagocyte FunctionClinical Infectious Diseases, 1987
- A STUDY OF THE INHIBITION OF STREPTOCOCCAL PROTEINASE BY SERA OF NORMAL AND IMMUNE ANIMALS AND OF PATIENTS INFECTED WITH GROUP A HEMOLYTIC STREPTOCOCCIJournal of Experimental Medicine, 1947